FDA Panel Judging Birth Control Risk Had Ties to Bayer

A Bayer-Schering employee examines YAZ
birth control pills in the company's factory
in Berlin, 10/27/11.
(photo: Bayer HealthCare AG)

Jeanne Lenzer and Keith Epstein, Washington Monthly
Excerpt: "The FDA's decision not to reveal its advisors' relationships with the drugs' manufacturers and Bayer raises serious questions about the agency's treatment of potential conflicts of interest, a historically problematic area for the department."
READ MORE